These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28427178)

  • 1. Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.
    Li L; Wu D; Yu Q; Li L; Wu P
    Oncotarget; 2017 May; 8(19):32298-32308. PubMed ID: 28427178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis.
    Wu P; Wu D; Zhao L; Huang L; Shen G; Huang J; Chai Y
    Oncotarget; 2016 Apr; 7(15):19863-83. PubMed ID: 26959884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
    Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
    Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer.
    Abdeljaoued S; Bettaieb L; Nasri M; Adouni O; Goucha A; Bouzaiene H; Boussen H; Rahal K; Gamoudi A
    Breast Dis; 2018; 37(3):109-114. PubMed ID: 29504520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma.
    Song BN; Chu IS
    Exp Mol Med; 2018 Jan; 50(1):e418. PubMed ID: 29303511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma.
    Ito T; Kohashi K; Yamada Y; Maekawa A; Kuda M; Furue M; Oda Y
    Histopathology; 2016 Jul; 69(1):63-71. PubMed ID: 26619071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System Review.
    Dai J; Yang L; Wang J; Xiao Y; Ruan Q
    Dis Markers; 2015; 2015():352478. PubMed ID: 26451068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of forkhead box M1 is associated poor survival in patients with nonsmall cell lung cancer.
    Liu B; Su F; Lin R; Teng H; Ju Y
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1121-S1123. PubMed ID: 30539856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of cyclin B1 in solid tumors: a meta-analysis.
    Ye C; Wang J; Wu P; Li X; Chai Y
    Oncotarget; 2017 Jan; 8(2):2224-2232. PubMed ID: 27903976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxM1: Repurposing an oncogene as a biomarker.
    Nandi D; Cheema PS; Jaiswal N; Nag A
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):74-84. PubMed ID: 28855104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
    He S; Liao B; Deng Y; Su C; Tuo J; Liu J; Yao S; Xu L
    BMC Cancer; 2017 Oct; 17(1):673. PubMed ID: 28978307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.
    Liang SK; Hsu CC; Song HL; Huang YC; Kuo CW; Yao X; Li CC; Yang HC; Hung YL; Chao SY; Wu SC; Tsai FR; Chen JK; Liao WN; Cheng SC; Tsou TC; Wang IC
    Oncogene; 2021 Jul; 40(30):4847-4858. PubMed ID: 34155349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight correlation between FoxM1 and FoxP3+ Tregs in gastric cancer and their clinical significance.
    Li X; Ma K; Song S; Shen F; Kuang T; Zhu Y; Liu Z
    Clin Exp Med; 2018 Aug; 18(3):413-420. PubMed ID: 29804142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Forkhead BOX M1 (FOXM1) gene expression in colorectal cancer.
    Rather TB; Parveiz I; Bhat GA; Rashid G; Wani RA; Khan IY; Mudassar S
    Clin Exp Med; 2023 Oct; 23(6):2385-2405. PubMed ID: 36318377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer.
    Zhang HG; Xu XW; Shi XP; Han BW; Li ZH; Ren WH; Chen PJ; Lou YF; Li B; Luo XY
    Clin Transl Oncol; 2016 May; 18(5):527-32. PubMed ID: 26370421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis.
    Zeng P; Chen MB; Zhou LN; Tang M; Liu CY; Lu PH
    Sci Rep; 2016 Sep; 6():33658. PubMed ID: 27645103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1.
    Jiao X; Yu W; Qian J; Chen Y; Wei P; Fang W; Yu G
    BMC Cancer; 2018 May; 18(1):570. PubMed ID: 29776401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1 predicts disease progression in non-muscle invasive bladder cancer.
    Rinaldetti S; Wirtz R; Worst TS; Hartmann A; Breyer J; Dyrskjot L; Erben P
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1701-1709. PubMed ID: 29959570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].
    Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.